Daxor (DXR) announces the expansion of its diagnostic solutions into two additional U.S. healthcare systems, further advancing the standard of care for cardiovascular and critical care patients nationwide. Daxor continues to drive healthcare transformation through its dual implementation models, tailored to meet the unique needs of diverse clinical settings. This strategic expansion includes: A premier regional referral center in East Tennessee has integrated Daxor’s advanced ezBVA Lab service into its cardiology practice. Our CLIA-certified laboratory service, based in Tennessee, leverages state-of-the-art BVA technology-based analysis to deliver comprehensive diagnostic results within 24 hours, enhancing precision care for outpatient cardiology services. A leading comprehensive healthcare facility in the Pacific Northwest has implemented Daxor’s on-site BVA analyzer system. This installation supports both inpatient and outpatient diagnostic needs across cardiology and intensive care departments, enabling immediate access to critical blood volume data that drives clinical decision-making.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXR:
- Daxor announces opening of new BVA program at Florida center
- Daxor announces expansion of BVA capabilities in three new hospitals
- Daxor to showcase blood volume analysis at Cardiovascular Transforum conference
- Daxor announces new data at ACC on blood volume analysis
- Daxor announces submission of Daxor BVA to FDA